$29.14
8.71% yesterday
NYSE, Mar 28, 09:18 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$29.14
-15.95 35.37% 1M
+10.72 58.20% 6M
+4.96 20.51% YTD
+13.67 88.36% 1Y
+23.98 464.73% 3Y
+19.24 194.34% 5Y
+19.34 197.35% 10Y
NYSE, Closing price Fri, Mar 28 2025
-2.78 8.71%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Market capitalization $6.47b
Enterprise Value $6.19b
P/E (TTM) P/E ratio 54.49
EV/FCF (TTM) EV/FCF 31.19
EV/Sales (TTM) EV/Sales 4.19
P/S ratio (TTM) P/S ratio 4.38
P/B ratio (TTM) P/B ratio 13.50
Revenue growth (TTM) Revenue growth 69.33%
Revenue (TTM) Revenue $1.48b
EBIT (operating result TTM) EBIT $68.00m
Free Cash Flow (TTM) Free Cash Flow $198.33m
Cash position $300.25m
EPS (TTM) EPS $0.53
P/E forward 48.75
P/S forward 2.80
EV/Sales forward 2.68
Short interest 28.00%
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Hims & Hers Health Inc. forecast:

6x Buy
35%
9x Hold
53%
2x Sell
12%

Analyst Opinions

17 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
35%
Hold
53%
Sell
12%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,477 1,477
69% 69%
100%
- Direct Costs 437 437
162% 162%
30%
1,039 1,039
47% 47%
70%
- Selling and Administrative Expenses 954 954
30% 30%
65%
- Research and Development Expense - -
-
-
85 85
422% 422%
6%
- Depreciation and Amortization 17 17
80% 80%
1%
EBIT (Operating Income) EBIT 68 68
289% 289%
5%
Net Profit 126 126
635% 635%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Neutral
The Motley Fool
about 10 hours ago
Hims & Hers (HIMS -8.84%) has seen incredibly high growth, but the market is skeptical that will continue. In this video, Travis Hoium shows just how cheap the stock is today.
Negative
The Motley Fool
one day ago
What goes up can come down. Investors who jumped on the Hims & Hers Health (HIMS -4.12%) bandwagon have experienced this pain first-hand.
Negative
Invezz
3 days ago
Hims & Hers stock price has imploded this year, erasing some of the gains made in 2024 when it became one of the top-performing companies in the US. HIMS has crashed to $33.35, down by over 54% from its highest point this year.
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,637
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today